Back to CS Candriam S.C.A.
KRYS
Showing 0 of 5 quarters
Position history for CSCandriam S.C.A.'s holdings in Krystal Biotech, Inc.
No. Candriam S.C.A. exited its KRYS (Krystal Biotech) position in Q1 2024. Its Q4 2023 13F listed 55,000 shares worth $6.8M. Candriam S.C.A. first reported KRYS in Q1 2023 and held it in 4 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.